Study of a valve treatment for severe leaking tricuspid valve
Part of Heart & circulation clinical trials.
This trial looks at a catheter-based procedure using the TricValve system for people with severe “tricuspid regurgitation” (a leaky tricuspid valve) who are very symptomatic. It may help reduce the backflow and improve heart function, especially for people who are too unwell for or not helped by standard options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your echocardiogram and right-heart measurements show severe tricuspid valve leaking with strong backflow pressure in the IVC and/or SVC
- CT scan shows your heart anatomy is suitable for the TricValve bicaval valve implant
- Your symptoms are severe (NYHA class III or IV) and you can walk at least 60 meters in a 6-minute walk test
- You can give consent (or your legal guardian can), and you can return for required follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, less-invasive device to fix the tricuspid valve in the heart for people with severe leakage. It may be an option if you are not a good candidate for traditional open-heart surgery and have tried other treatments.
This trial tests a new device, called the Laplace TTVR System, to replace the tricuspid valve in people whose leaky valve (tricuspid regurgitation) continues to cause symptoms despite medical treatment. It may help if you have severe symptoms and are not a candidate for open-heart surgery.
This trial tests a new, less invasive valve device (TricValve) for people with severe tricuspid regurgitation who are not good candidates for open-heart surgery. It aims to see if this device can help your heart pump better and improve your symptoms.
This trial tests whether a new minimally invasive valve replacement device (put through a catheter) can improve health in people with severe right-sided tricuspid valve leaking. It’s for patients who are considered too high-risk for standard open-heart tricuspid surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
Hear when a new Severe Tricuspid Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.